Valuation: Axogen, Inc.

Market Cap 244.03Cr 213.33Cr 196.05Cr 182.74Cr 346.61Cr 23TCr 351.87Cr 2.35TCr 914.98Cr 11TCr 916Cr 896.33Cr 39TCr P/E 2026 *
-118x
P/E 2027 * 297x
Enterprise Value 244.03Cr 213.33Cr 196.05Cr 182.74Cr 346.61Cr 23TCr 351.87Cr 2.35TCr 914.98Cr 11TCr 916Cr 896.33Cr 39TCr EV / Sales 2026 *
9.01x
EV / Sales 2027 * 7.66x
Free-Float
96.5%
Yield 2026 *
-
Yield 2027 * -
1 day+4.25%
1 week+2.14%
Current month-0.65%
1 month+12.95%
3 months+33.25%
6 months+48.03%
Current year+40.21%
1 week 42.18
Extreme 42.18
46.95
1 month 40.32
Extreme 40.325
46.95
Current year 27.54
Extreme 27.54
46.95
1 year 10.71
Extreme 10.71
46.95
3 years 3.45
Extreme 3.45
46.95
5 years 3.45
Extreme 3.45
46.95
10 years 3.45
Extreme 3.45
56.85
Manager TitleAgeSince
Chief Executive Officer 66 09/08/2024
Director of Finance/CFO 42 12/05/2025
Chief Tech/Sci/R&D Officer - 04/01/2024
Director TitleAgeSince
Chairman 70 09/08/2024
Director/Board Member 65 01/09/2016
Director/Board Member 68 19/07/2021
Date Insider Type Main position Quantity % Market Cap.
24/06Free

Director

4,392 0.0083%
24/06Free

Director

4,392 0.0083%
24/06Free

Director

4,392 0.0083%
Change 5-day change 1-year change 3-year change Capi.($)
+4.25%+2.14%+319.85%+418.53% 244.03Cr
+1.97%+2.03%+21.92%+0.83% 19TCr
+5.87%+5.27%-21.76%+26.78% 15TCr
+2.17%+0.89%-2.59%-16.42% 14TCr
+4.83%+2.06%-56.73%-15.69% 6.71TCr
+2.59%+3.95%+22.89%+3.15% 5.43TCr
+0.03%+2.19%-25.48%-31.00% 4.46TCr
+0.31%+1.30%+8.30%+43.25% 3.72TCr
-2.02%-3.91%+7.67%+9.53% 3.69TCr
+4.24%+4.66%-18.42%-2.34% 3.02TCr
Average +2.42%+2.78%+25.57%+43.66% 7.58TCr
Weighted average by Cap. +2.79%+3.44%-2.99%+3.36%

Financials

2026 *2027 *
Net sales 27Cr 24Cr 22Cr 20Cr 38Cr 2.58TCr 39Cr 261.26Cr 101.56Cr 1.27TCr 101.68Cr 99Cr 4.37TCr 32Cr 28Cr 26Cr 24Cr 45Cr 3.03TCr 46Cr 307.11Cr 119.39Cr 1.49TCr 119.52Cr 116.95Cr 5.14TCr
Net income -2.12Cr -1.85Cr -1.7Cr -1.59Cr -3.01Cr -201.57Cr -3.05Cr -20Cr -7.94Cr -99Cr -7.95Cr -7.78Cr -341.43Cr 80.57L 70.43L 64.73L 60.33L 1.14Cr 77Cr 1.16Cr 7.77Cr 3.02Cr 38Cr 3.02Cr 2.96Cr 129.94Cr
Net Debt - -
Logo Axogen, Inc.
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel.
Employees
622
Date Price Change Volume
02/26/02 $45.89 +4.25% 24,09,600
01/26/01 $44.02 -4.70% 14,02,768
30/26/30 $46.19 +3.29% 12,28,771
29/26/29 $44.72 -0.47% 11,67,237
26/26/26 $44.93 +0.99% 32,80,197
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
45.89USD
Average target price
50.78USD
Spread / Average Target
+10.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AXGN Stock